The Column Group — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Exonics TherapeuticsNov 2017SEC filinghigh confidence
BiotechWatertown, US
John Ripple(Executive Officer, Director)Jesper Gromada(Executive Officer)H. James Magee(Executive Officer)Roger Perlmutter(Director)
Board seatDavid GoeddelJeenJoo Kang· per SEC Form D · $42M raise · filed Nov 2018
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.